Search

Your search keyword '"Mathioudakis AG"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Mathioudakis AG" Remove constraint Author: "Mathioudakis AG"
135 results on '"Mathioudakis AG"'

Search Results

1. Inhaled Corticosteroids Particle Size and Risk of Hospitalization Due to Exacerbations and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. A Nationwide Cohort Study

2. Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological Study

3. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs

4. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

5. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

6. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

7. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

8. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019

10. ERS statement : a core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations

11. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making

12. Systematic review on women's values and preferences concerning breast cancer screening and diagnostic services

13. Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis

14. Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis

16. Vasoactive intestinal peptide inhaled agonists: Potential role in respiratory therapeutics

17. Patient-centred composite scores as tools for assesment of response to biological therapy for paediatric and adult severe asthma.

18. European Respiratory Society guidelines for the diagnosis and management of pulmonary alveolar proteinosis.

19. Rethinking Blood Eosinophils for Assessing Inhaled Corticosteroids Response in COPD: A Post Hoc Analysis From the FLAME Trial.

20. Steroids in severe community-acquired pneumonia.

21. GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses.

22. Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis.

23. Immunomodulatory drugs in sepsis: a systematic review and meta-analysis.

24. Unravelling the complexity of ventilator-associated pneumonia: a systematic methodological literature review of diagnostic criteria and definitions used in clinical research.

25. Current options in the management of tree nut allergy: A systematic review and narrative synthesis.

26. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO.

27. ERS International Congress 2023: highlights from the Airway Diseases Assembly.

28. Inhaled versus systemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis.

30. Performance Characteristics of Basophil Activation Tests for Diagnosing Penicillin Allergy: A Meta-Analysis.

31. Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis.

32. Clinical trials of pneumonia management assess heterogeneous outcomes and measurement instruments.

33. Prevalence and clinical implications of respiratory viruses in asthma during stable disease state and acute attacks: Protocol for a meta-analysis.

34. Impact of self-reported environmental mould exposure on COPD outcomes.

35. The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease.

36. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition.

37. Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022.

38. ERS International Congress 2022: highlights from the Airway Diseases Assembly.

39. Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID.

40. Current and Optimal Practices in Childhood Asthma Monitoring Among Multiple International Stakeholders.

41. Core outcome sets, developed collaboratively with patients, can improve the relevance and comparability of clinical trials.

42. Impact of triple therapy on mortality in COPD.

43. Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis.

44. How to peer review: practical advice for early career researchers.

45. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe.

46. GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions.

47. West Nile Disease Symptoms and Comorbidities: A Systematic Review and Analysis of Cases.

48. Peripheral neuropathy: A neglected cause of disability in COPD - A narrative review.

49. Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population.

50. Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.

Catalog

Books, media, physical & digital resources